Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (4) , 943-955
- https://doi.org/10.1016/s0360-3016(02)04146-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Late effects of radiation therapy for prostate carcinoma: The patient's perspective of bladder, bowel and sexual morbidityAustralasian Radiology, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- A retrospective study of the effects of pelvic irradiation for gynecological cancer on anorectal functionInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Acute morbidity of radiation therapy for prostate carcinomaAustralasian Radiology, 1996
- The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853European Journal Of Cancer, 1996
- Late effects toxicity scoring: The soma scaleInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Carcinoma of the prostate: Results of radical radiotherapy (1970–1985)International Journal of Radiation Oncology*Biology*Physics, 1993
- Gastrointestinal function in chronic radiation enteritis--effects of loperamide-N-oxide.Gut, 1993
- Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation twenty-two years' experience (1962–1984)Urology, 1990
- Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgencyDigestive Diseases and Sciences, 1982